All updates
All updates
today 30FDA Drugs评分99 FDA Drugs评分44 Drugs@FDA Data Files
FDA Drugs评分55 Drug Products Committee Vacancies
FDA Drugs评分3131 Babikian Healthcare Products CJSC - 730513 - 09/21/2026
FDA Drugs精选评分6666 Fresenius Kabi AG - 733107 - 09/22/2026
FDA Drugs评分3737 Celmade - 735876 - 09/14/2026
FDA Drugs评分3939 Bentley Laboratories LLC - 732028 - 09/17/2026
FDA Drugs评分3333 M11 Clinical Electronic Structured Harmonised Protocol
FDA Drugs评分22 Generic Drug Facilities, Sites and Organization Lists
FDA Drugs评分1212 Project Orbis
FDA Drugs评分1111 Study Data Standards Resources
监管与产业动态评分2525 White House lays groundwork to reshore production of 86 essential medicines - Fierce Pharma
BioSpace精选评分4545 Milestone Sanfilippo nod helps Ultragenyx regroup after tough Angelman defeat
BioSpace精选评分5050 Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
BioSpace精选评分6363 AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
Endpoints News评分4040 Merck, Daiichi scrap FDA application for B7-H3 ADC in lung cancer
Endpoints News精选评分6060 Nonprofits' gene therapy for rare immune disease will cost $3.25M
Endpoints News评分77 White House takes stock of US-based manufacturing for 86 essential drugs
Endpoints News精选评分5050 Egetis Therapeutics' Emcitate cleared by FDA for rare X-linked genetic disease
STAT News评分5050 STAT+: AbbVie wins FDA nod for Parkinson’s pill
STAT News评分2020 Trump administration asks Supreme Court to allow transgender medical care restrictions in prison
STAT News评分1818 STAT+: Overton won’t get a vote before midterms
监管与产业动态评分3737 US details rules for 0% specialty pharmaceutical tariff exemptions - Fierce Pharma
FDA Drugs评分2424 Supporting Clinical Practice Guidelines for Drugs with Abuse Potential
FDA Drugs精选评分4747 VeganicSKN Limited - 719883 - 02/09/2026
FDA Drugs精选评分4545 Curia New York, Inc. - 728790 - 09/18/2026
FDA Drugs评分1717 Stream2Sea, LLC - 718983 - 02/02/2026
FDA Drugs评分4141 Kellin Chemicals Co., Ltd. - 716228 - Zhangjiagang
STAT News评分2626 STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
FDA Press Releases精选评分6565 FDA Approves First Treatment for MCT8 Deficiency
监管与产业动态评分5656 Roche’s Gazyva secures FDA nod for idiopathic nephrotic syndrome, extending autoimmune pivot - Fierce Pharma
BioSpace精选评分6363 FDA nod for Mirum’s Atebrioz makes 3 options for ultra-rare bone disease
BioPharma Dive精选评分5656 Merck, Daiichi end plans to seek speedy approval of lung cancer ADC
中文产业新闻Chinese source评分6060 礼来非共价BTK抑制剂匹妥布替尼在华获批慢性淋巴细胞白血病/小淋巴细胞淋巴瘤初治适应症
监管与产业动态评分5353 AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease - Fierce Pharma
中文产业新闻Chinese source评分6161 礼来长效胰岛素 Efsitora alfa 获 FDA 批准用于 2 型糖尿病
中文产业新闻精选Chinese source评分7070 FDA 批准默沙东/卫材贝组替凡联合仑伐替尼用于既往接受 PD-1/PD-L1 抑制剂治疗的晚期透明细胞肾细胞癌
监管与产业动态评分4747 Signal or noise? > Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #healthcare #competitivemarketing
中文产业新闻精选Chinese source评分6363 全球首个iPSC来源再生医学产品在日本获批治疗帕金森病
中文产业新闻精选Chinese source评分7070 FcRn阻断剂nipocalimab获FDA批准用于治疗wAIHA